Gene · 83737
Papers2,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The JMJD family histone demethylases: structure, mechanism of action, diseases and therapeutic targets. | Mol Biomed | 2026 | 41857315 | PubTator, text mining | PubMed |
| Maternal opioid use disorder and hepatitis C infection in pregnancy reshape the peripheral immune landscape at term. | EBioMedicine | 2026 | 41849830 | PubTator, text mining | PubMed |
| From Single-Cell Clusters to Causality: ITCH Engagement for CKD Uncovered by Integrative Analysis of MR and MAGMA. | FASEB J | 2026 | 41817007 | PubTator, text mining | PubMed |
| FBXW7 Targets the SPT6-ΔNp63 Axis for Degradation to Inhibit Esophageal Tumorigenesis Induced by 4-Nitroquinoline N-Oxide. | MedComm (2020) | 2026 | 41799933 | PubTator, text mining | PubMed |
| Circular RNAs: Key Regulators of Tumor Metabolic Reprogramming and Clinical Translation. | Oncol Res | 2026 | 41799520 | PubTator, text mining | PubMed |
| Divergent roles of circMPP6 and its parental gene MPP6 in non-small cell lung cancer. | Front Cell Dev Biol | 2026 | 41799439 | PubTator, text mining | PubMed |
| ZG16 represses tumor progression and M2 polarization of tumor-associated macrophages in hepatocellular carcinoma by promoting ubiquitination and degradation of SNX9 via binding to ITCH. | Hepatol Int | 2026 | 41781795 | PubTator, text mining | PubMed |
| Proteasomal control of transcription factors: mechanisms, regulation and dysregulation. | Cell Mol Life Sci | 2026 | 41764121 | PubTator, text mining | PubMed |
| Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms. | Biomolecules | 2026 | 41750393 | PubTator, text mining | PubMed |
| Multi-omics analysis identifies TLRscore for prognostic prediction and highlights TLR8 in macrophage-mediated antitumor immunity of lung adenocarcinoma. | Front Immunol | 2026 | 41743724 | PubTator, text mining | PubMed |
| ALIX and ITCH localize to the base of primary cilia and negatively regulate ciliary Polycystin-2 levels. | BMC Mol Cell Biol | 2026 | 41742018 | PubTator, text mining | PubMed |
| PFKP binding AMOTL1 promotes tumor aerobic glycolysis and epithelial-mesenchymal transition by modulating Hippo pathway in head and neck cancer. | J Transl Int Med | 2026 | 41727965 | PubTator, text mining | PubMed |
| Identification of ubiquitination-related signature genes for predicting kidney transplant rejection. | Sci Rep | 2026 | 41667756 | PubTator, text mining | PubMed |
| Golgi fragmentation driven by the USP11-ITCH axis triggers autolysosomal failure in neurodegeneration. | Autophagy | 2026 | 41655130 | PubTator, text mining | PubMed |
| HCV infection induces ubiquitin-dependent degradation of LATS1, inactivating the Hippo pathway and upregulating transcription of the CYR61 and CTGF genes. | J Gen Virol | 2026 | 41642640 | PubTator, text mining | PubMed |
| FOLR1 Mediated by ITCH Promotes Paclitaxel Resistance by Suppressing Pyroptosis in Nasopharyngeal Carcinoma. | Arch Pharm (Weinheim) | 2026 | 41635097 | PubTator, text mining | PubMed |
| The impact of inhibiting the Hippo signaling pathway effector molecule YAP1 on in vitro glioblastoma and glioblastoma stem cells. | Sci Rep | 2026 | 41577723 | PubTator, text mining | PubMed |
| A TRIM21-UCHL3-ITCH-SIPA1 axis promotes colorectal cancer growth and metastasis. | Cancer Lett | 2026 | 41412211 | PubTator, text mining | PubMed |
| MAML1 drives Notch and Hedgehog oncogenic pathways by inhibiting Itch activity in triple-negative breast cancer. | Cell Death Differ | 2026 | 41272291 | PubTator, text mining | PubMed |
| The Crosstalk Between CRL5 and APC/C E3 Ligases Regulates Metastasis and Chemosensitivity of Cancer Cells. | Adv Sci (Weinh) | 2026 | 41159544 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/83737/papers?page=2